Candamo, Amor .

HRN: 26-29-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
01/12/2025
01/18/2025
IVTT
25mg
Q24h
T/c Late Onset Neonatal Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: